Status:
COMPLETED
Relenza® Sentinel Site Monitoring Program in Japan
Lead Sponsor:
GlaxoSmithKline
Conditions:
Influenza, Human
Eligibility:
All Genders
Brief Summary
To collect background information of patients receiving a prescription for Relenza® and study risk factors etc. for adverse drug reactions collected through spontaneous reporting. In particular, to ch...
Detailed Description
1. Objectives To collect background information of patients receiving a prescription for Relenza® and study risk factors etc. for adverse drug reactions collected through spontaneous reporting. In par...
Eligibility Criteria
Inclusion
- Prescribed Relenza® for the purpose of either treatment or prophylaxis of influenza
Exclusion
- N/A
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
1575 Patients enrolled
Trial Details
Trial ID
NCT01199744
Start Date
November 1 2009
End Date
April 1 2010
Last Update
July 6 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.